SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022881
Filing Date
2024-04-29
Accepted
2024-04-29 14:33:18
Documents
5
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A edge20024963x2_def14a.htm DEF 14A 1187661
2 edge20024963x1_pc01.jpg GRAPHIC 658479
3 edge20024963x1_pc02.jpg GRAPHIC 429831
4 edge20024963x2_pvp01x1.jpg GRAPHIC 98754
5 edge20024963x2_pvp02x1.jpg GRAPHIC 107145
  Complete submission text file 0001140361-24-022881.txt   2970390
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 24889644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)